Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection

Haemophilia

Volumn 16, Issue 5, 2010, Pages 778-785

  Vidovic, N ^a   Lochowsky, R S ^a   Goldmann, G ^a   Rockstroh, J ^a   Wasmuth, J C ^a   Spengler, U ^a   Sauerbruch, T ^a   Lammert, F ^b   Oldenburg, J ^a   Grunhage F ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Elastography; Fibrosis; Haemophilia; Hepatitis C; HIV; Non invasive

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; BILIRUBIN BLOOD LEVEL; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; FIB 4; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER FIBROSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MIXED INFECTION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BODY MASS INDEX; COHORT STUDIES; ELASTICITY IMAGING TECHNIQUES; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MIDDLE AGED; PLATELET COUNT; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77955937493     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02204.x     Document Type: Article

References (44)

1. Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut 2000, 47:845-51.
2. Posthouwer D, Plug I, van der Bom JG, Fischer K, Rosendaal FR, Mauser-Bunschoten EP. Hepatitis C and health-related quality of life among patients with hemophilia. Haematologica 2005, 90:846-50.
3. Ahmed MM, Mutimer DJ, Martin B, Elias E, Wilde JT. Hepatitis C viral load, genotype and histological severity in patients with bleeding disorders. Haemophilia 1999, 5:49-55.
4. Goedert JJ, Eyster ME, Lederman MM. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 2002, 100:1584-9.
5. Posthouwer D, Fischer K, van Erpecum KJ, Mauser-Bunschoten EP. The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders. Transfusion 2006, 46:1360-6.
6. Tencer T, Friedman HS, Li-McLeod J, Johnson K. Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection. J Manag Care Pharm 2007, 13:790-8.
7. Posthouwer D, Yee TT, Makris M. Antiviral therapy for chronic hepatitis C in patients with inherited bleeding disorders: an international, multicenter cohort study. J Thromb Haemost 2007, 5:1624-9.
8. Qurishi N, Kreuzberg C, Luchters G. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003, 362:1708-13.
9. Schulman S, Kinnman N, Lindmarker P, von Sydow M. A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders. Haemophilia 2002, 8:129-35.
10. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004, 39:1147-71.
11. DiMichele DM, Mirani G, Wilfredo Canchis P, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 2003, 9:613-8.
12. Sterling RK, Lyons CD, Stravitz RT. Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease. Haemophilia 2007, 13:164-71.
13. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003, 39:239-44.
14. Regev A. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002, 97:2614-8.
15. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003, 38:427-32.
16. Pinzani M, Vizzutti F, Arena U, Marra F. Technology insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol 2008, 5:95-106.
17. Cacoub P, Carrat F, Bedossa P. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study - ANRS HC02. J Hepatol 2008, 48:765-73.
18. de Ledinghen V. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus co-infected patients. J Acquir Immune Defic Syndr 2006, 41:175-9.
19. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007, 46:912-21.
20. Shaheen AA, Myers RP. Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/Hepatitis C coinfection. HIV Clin Trials 2008, 9:43-51.
21. Sagir A, Erhardt A, Schmitt M, Haussinger D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008, 47:592-5.
22. Castera L. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005, 128:343-50.
23. Sterling RK. Development of a simple non-invasive index to predict significant fibrosis in patients with chronic hepatitis C. Hepatology 2006, 43:1317-25.
24. Vallet-Pichard A, Mallet V, Pol S. Predictive value of FIB-4 versus fibrotest, APRI, FIBROINDEX and FORNS to noninvasively estimate fibrosis in hepatitis C. Hepatology 2008, 47:763.
25. Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007, 102:2589-600.
26. Ogawa E, Furusyo N, Toyoda K, Takeoka H, Maeda S, Hayashi J. The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin. Antiviral Res 2009, 83:127-34.
27. Vallet-Pichard A, Mallet V, Nalpas B. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology 2007, 46:32-6.
28. Sebastiani G, Vario A, Guido M. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006, 44:686-93.
29. Leroy V. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007, 46:775-82.
30. Standish RA. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006, 55:569-78.
31. Sebastiani G, Halfon P, Castera L. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009, 49:1821-7.
32. Grünhage F, Lammert F. Assessment of hepatic fibrosis in chronic viral hepatitis. Hepatology - A Clinical Textbook 2009, Mauss S, Berg TRockstroh JSarrazin CWedemeyer H. In, eds, Düsseldorf, Flying Publisher
33. Shastry L, Wilson T, Lascher S, Nord JA. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients. AIDS 2007, 21:2541-3.
34. Ziol M, Handra-Luca A, Kettaneh A. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005, 41:48-54.
35. Foucher J, Chanteloup E, Vergniol J. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006, 55:403-8.
36. Posthouwer D, Mauser-Bunschoten EP, Fischer K, VANE KJ, DEK RJ. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography. J Thromb Haemost 2007, 5:25-30.
37. Arena U, Vizzutti F, Abraldes J. Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008, 57:1288-93.
38. Kirk GD, Astemborski J, Mehta SH. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 2009, 48:963-72.
39. Masaki N, Imamura M, Kikuchi Y, Oka S. Usefulness of elastometry in evaluating the extents of liver fibrosis in hemophiliacs coinfected with hepatitis C virus and human immunodeficiency virus. Hepatol Res 2006, 35:135-9.
40. de Ledinghen V, Barreiro P, Foucher J. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat 2008, 15:427-33.
41. Sanchez-Conde M, Montes-Ramirez ML, Miralles P. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat 2009, Epub ahead of print
42. Lee C, Dusheiko G. The natural history and antiviral treatment of hepatitis C in haemophilia. Haemophilia 2002, 8:322-9.
43. Brau N, Salvatore M, Rios-Bedoya CF. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006, 44:47-55.
44. Verma S. HAART attenuates liver fibrosis in patients with HIV/HCV co-infection: fact or fiction? J Antimicrob Chemother 2006, 58:496-501.